Evidence map›Paper›PMID 41721025›Full record

ArticleJournal of neurology2026

Disability progression in multiple sclerosis: a latent class analysis of predictors.

Jie Guo, Tomas Olsson, Lars Alfredsson, Anna Karin Hedström

Abstract read
In one paragraph

Article in Journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jie GuoDepartment of Nutrition and Health, China Agricultural University, Beijing, China.
Tomas OlssonDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Lars AlfredssonInstitute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Anna Karin HedströmDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. anna.hedstrom@ki.se.ORCID http://orcid.org/0000-0002-6612-4749

Funding

Forskningsrådet om Hälsa, Arbetsliv och Välfärd 2015-00195Forskningsrådet om Hälsa, Arbetsliv och Välfärd 2019-00697Swedish Brain Foundation FO2020-0077Swedish Brain Foundation FO2024-0344Vetenskapsrådet 2016-02349Vetenskapsrådet 2020-01998
6 · The paper itself

Abstract

backgroundMultiple sclerosis (MS) is a heterogeneous disease with highly variable long-term outcomes. We aimed to identify patterns of disability progression and their determinants to improve individualized risk assessment and support clinical decision-making.

methodsWe applied latent class trajectory modeling to Expanded Disability Status Scale (EDSS) data from 3163 newly diagnosed relapsing-onset MS cases in the Swedish Epidemiological Investigation of MS (2005-2019). Baseline demographics, clinical, and lifestyle data were collected at diagnosis, and participants were followed through the Swedish MS registry. Multivariate logistic regression was used to examine associations between baseline characteristics and trajectory group membership. Kaplan-Meier analysis estimated time to confirmed disability worsening, EDSS 3 and EDSS 4 across trajectory groups.

resultsSeven distinct EDSS trajectories were identified. Group 4 (n = 1149) was the most common and characterized by stable, low disability. Groups 5-7 showed steadily increasing disability and were categorized as unfavorable (n = 662). In multivariate models, older age at diagnosis, longer baseline disease duration, higher baseline EDSS score, more frequent early relapses, poor cognitive performance, and autoimmune comorbidities were associated with unfavorable progression. Among lifestyle factors, obesity, smoking, and low sun exposure were linked to worse outcomes, while high physical activity decreased the odds of unfavorable progression. No significant association was observed for baseline vitamin D levels. Time to confirmed disability progression outcomes differed substantially across trajectory groups. DISCUSSION: Early clinical and lifestyle factors were associated with long-term outcomes. These findings illustrate the heterogeneity of MS progression and support further investigation of early modifiable factors influencing long-term outcomes.

Indexed as

Disease ProgressionMultiple SclerosisMultiple Sclerosis, Relapsing-RemittingAdultDisability EvaluationFemaleHumansLatent Class AnalysisMaleMiddle AgedRegistriesSwedenClinical and lifestyle predictorsDisability progressionEDSSLatent class analysisMultiple sclerosisPrognosisProgressionProspective cohortTrajectories

Identifiers

PMID41721025
PMCPMC12923449

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.